{"id":14322,"date":"2019-12-03T16:57:00","date_gmt":"2019-12-03T16:57:00","guid":{"rendered":"https:\/\/oxfordcorp.com\/?p=14322"},"modified":"2023-10-13T16:10:43","modified_gmt":"2023-10-13T16:10:43","slug":"fda-remediation-for-cardiovascular-device-maker","status":"publish","type":"post","link":"https:\/\/www.oxfordcorp.com\/en\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/","title":{"rendered":"FDA Remediation for Cardiovascular Device Maker"},"content":{"rendered":"<p><em>Discover how Oxford\u2019s consultants helped to remediate the issue and pass the FDA re-inspection.<\/em><\/p>\n<p><strong>INDUSTRY<\/strong><br \/>\nMedical Device<\/p>\n<p><strong>SERVICES<\/strong><br \/>\nRemediation<br \/>\nDocumentation<br \/>\nCorrective &amp; Preventative Action (CAPA)<br \/>\nQuality Systems Improvement<\/p>\n<p><strong>SKILLS<\/strong><br \/>\nFDA Compliance<br \/>\nQuality Management Systems (QMS)<\/p>\n<p><strong>The Challenge<\/strong><br \/>\nFollowing receipt of an FDA Warning Letter, a global cardiovascular medical device manufacturer engaged Oxford to support a remediation effort. Our client\u2019s large-scale production operation in Germany urgently needed support to remediate technical documentation, processes, and systems in order to pass the FDA re-inspection and remove the warning letter status.<\/p>\n<p><strong>The Solution<\/strong><br \/>\nWe supplied 16 senior-level consultants over a two-year period. They were integrated into a classic remediation and warning letter environment that included an internal remediation task force and consultants from multiple agencies. Our consultants worked on several work streams, including:<\/p>\n<ul>\n<li>Assessing 50-60 technical files in collaboration with the R&amp;D and Regulatory teams, ensuring that the technical and design history files were updated to meet ISO and CFR standards. The products included disposables used in external heart and lung machines, catheters, membranes and oxygenators.<\/li>\n<li>Taking ownership of CAPAs for sterilization remediation and writing reports and validation protocols for sterilization and bioburden testing.<\/li>\n<li>Handling all quality-related topics, maintaining and further developing the quality management system in accordance with the requirements of the ISO 13485, GMP and CFR 820.<\/li>\n<li>Monitoring and optimizing processes and documentation and providing active risk management.<\/li>\n<\/ul>\n<p><strong>The Result<\/strong><br \/>\nWhile our client continued to strive towards FDA compliance, Oxford consultants played vital roles in leading and executing compliance programs that were essential to our client\u2019s European business. The company selected Oxford as a preferred supplier based on a proven ability to deliver skilled consultants into a very challenging and fast-paced environment at short notice.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Discover how Oxford\u2019s consultants helped to remediate the issue and pass the FDA re-inspection. INDUSTRY Medical Device SERVICES Remediation Documentation [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":15190,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[181],"tags":[113],"category-tag":[],"class_list":["post-14322","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-case-study","tag-life-sciences"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Remediation for Cardiovascular Device Maker - Oxford Global Resources<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Remediation for Cardiovascular Device Maker\" \/>\n<meta property=\"og:description\" content=\"Discover how Oxford\u2019s consultants helped to remediate the issue and pass the FDA re-inspection. INDUSTRY Medical Device SERVICES Remediation Documentation [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxford Global Resources\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-03T16:57:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-13T16:10:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2019\/12\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"516\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luke Summers\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luke Summers\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/\"},\"author\":{\"name\":\"Luke Summers\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#\\\/schema\\\/person\\\/e880f6edc6bcf421204f294431943cd3\"},\"headline\":\"FDA Remediation for Cardiovascular Device Maker\",\"datePublished\":\"2019-12-03T16:57:00+00:00\",\"dateModified\":\"2023-10-13T16:10:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/\"},\"wordCount\":291,\"image\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.oxfordcorp.com\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg\",\"keywords\":[\"Life Sciences\"],\"articleSection\":[\"Case Study\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/\",\"url\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/\",\"name\":\"FDA Remediation for Cardiovascular Device Maker - Oxford Global Resources\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.oxfordcorp.com\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg\",\"datePublished\":\"2019-12-03T16:57:00+00:00\",\"dateModified\":\"2023-10-13T16:10:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#\\\/schema\\\/person\\\/e880f6edc6bcf421204f294431943cd3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.oxfordcorp.com\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.oxfordcorp.com\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg\",\"width\":1600,\"height\":430,\"caption\":\"oxford fda remediation for cardiovascular device maker 0\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/insights\\\/case-study\\\/fda-remediation-for-cardiovascular-device-maker\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.oxfordcorp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Remediation for Cardiovascular Device Maker\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/\",\"name\":\"Oxford Global Resources\",\"description\":\"Global\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.oxfordcorp.com\\\/de\\\/#\\\/schema\\\/person\\\/e880f6edc6bcf421204f294431943cd3\",\"name\":\"Luke Summers\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g\",\"caption\":\"Luke Summers\"},\"url\":\"https:\\\/\\\/www.oxfordcorp.com\\\/en\\\/insights\\\/author\\\/lsummersthiel-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA Remediation for Cardiovascular Device Maker - Oxford Global Resources","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/","og_locale":"en_GB","og_type":"article","og_title":"FDA Remediation for Cardiovascular Device Maker","og_description":"Discover how Oxford\u2019s consultants helped to remediate the issue and pass the FDA re-inspection. INDUSTRY Medical Device SERVICES Remediation Documentation [&hellip;]","og_url":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/","og_site_name":"Oxford Global Resources","article_published_time":"2019-12-03T16:57:00+00:00","article_modified_time":"2023-10-13T16:10:43+00:00","og_image":[{"width":1920,"height":516,"url":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2019\/12\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg","type":"image\/jpeg"}],"author":"Luke Summers","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Luke Summers","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/#article","isPartOf":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/"},"author":{"name":"Luke Summers","@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/e880f6edc6bcf421204f294431943cd3"},"headline":"FDA Remediation for Cardiovascular Device Maker","datePublished":"2019-12-03T16:57:00+00:00","dateModified":"2023-10-13T16:10:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/"},"wordCount":291,"image":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2019\/12\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg","keywords":["Life Sciences"],"articleSection":["Case Study"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/","url":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/","name":"FDA Remediation for Cardiovascular Device Maker - Oxford Global Resources","isPartOf":{"@id":"https:\/\/www.oxfordcorp.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/#primaryimage"},"image":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2019\/12\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg","datePublished":"2019-12-03T16:57:00+00:00","dateModified":"2023-10-13T16:10:43+00:00","author":{"@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/e880f6edc6bcf421204f294431943cd3"},"breadcrumb":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/#primaryimage","url":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2019\/12\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg","contentUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2019\/12\/oxford-fda-remediation-for-cardiovascular-device-maker_0.jpeg","width":1600,"height":430,"caption":"oxford fda remediation for cardiovascular device maker 0"},{"@type":"BreadcrumbList","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/fda-remediation-for-cardiovascular-device-maker\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oxfordcorp.com\/en\/"},{"@type":"ListItem","position":2,"name":"FDA Remediation for Cardiovascular Device Maker"}]},{"@type":"WebSite","@id":"https:\/\/www.oxfordcorp.com\/de\/#website","url":"https:\/\/www.oxfordcorp.com\/de\/","name":"Oxford Global Resources","description":"Global","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oxfordcorp.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/e880f6edc6bcf421204f294431943cd3","name":"Luke Summers","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3d7d4c9724f33e3a19ac78af573b29ed6164c2ceffe51f72aff7df98b279e3de?s=96&d=mm&r=g","caption":"Luke Summers"},"url":"https:\/\/www.oxfordcorp.com\/en\/insights\/author\/lsummersthiel-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/posts\/14322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/comments?post=14322"}],"version-history":[{"count":0,"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/posts\/14322\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/media\/15190"}],"wp:attachment":[{"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/media?parent=14322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/categories?post=14322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/tags?post=14322"},{"taxonomy":"category-tag","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/en\/wp-json\/wp\/v2\/category-tag?post=14322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}